189 related articles for article (PubMed ID: 21548851)
21. Association of the F13A1 Val34Leu polymorphism and recurrent pregnancy loss: A meta-analysis.
Jung JH; Kim JH; Song GG; Choi SJ
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():234-240. PubMed ID: 28683377
[TBL] [Abstract][Full Text] [Related]
22. FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct.
Akar N; Dönmez B; Deda G
J Child Neurol; 2007 Feb; 22(2):222-4. PubMed ID: 17621488
[TBL] [Abstract][Full Text] [Related]
23. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
[TBL] [Abstract][Full Text] [Related]
24. No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population.
Cho KH; Kim BC; Kim MK; Shin BA
J Korean Med Sci; 2002 Apr; 17(2):249-53. PubMed ID: 11961312
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
Dossenbach-Glaninger A; van Trotsenburg M; Dossenbach M; Oberkanins C; Moritz A; Krugluger W; Huber J; Hopmeier P
Clin Chem; 2003 Jul; 49(7):1081-6. PubMed ID: 12816904
[TBL] [Abstract][Full Text] [Related]
26. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
27. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
28. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
[TBL] [Abstract][Full Text] [Related]
29. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.
Wartiovaara U; Perola M; Mikkola H; Tötterman K; Savolainen V; Penttilä A; Grant PJ; Tikkanen MJ; Vartiainen E; Karhunen PJ; Peltonen L; Palotie A
Atherosclerosis; 1999 Feb; 142(2):295-300. PubMed ID: 10030380
[TBL] [Abstract][Full Text] [Related]
30. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
Slowik A; Dziedzic T; Pera J; Figlewicz DA; Szczudlik A
Cerebrovasc Dis; 2005; 19(3):165-70. PubMed ID: 15644629
[TBL] [Abstract][Full Text] [Related]
31. Coagulation factor XIII Val34Leu gene polymorphism and Alzheimer's disease.
Gerardino L; Papaleo P; Flex A; Gaetani E; Fioroni G; Pola P; Pola R
Neurol Res; 2006 Dec; 28(8):807-9. PubMed ID: 17288735
[TBL] [Abstract][Full Text] [Related]
32. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
33. Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
Küper MA; Schüle R; Mayer P; Königsrainer A; Beckert S
Diabet Med; 2012 Dec; 29(12):1596-9. PubMed ID: 22578139
[TBL] [Abstract][Full Text] [Related]
34. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
Attié-Castro FA; Zago MA; Lavinha J; Elion J; Rodriguez-Delfin L; Guerreiro JF; Franco RF
Thromb Haemost; 2000 Oct; 84(4):601-3. PubMed ID: 11057857
[TBL] [Abstract][Full Text] [Related]
35. Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease.
Saibeni S; Vecchi M; Faioni EM; Franchi F; Rondonotti E; Borsi G; de Franchis R
Dig Liver Dis; 2003 Jan; 35(1):32-6. PubMed ID: 12725605
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of the angiotensin converting enzyme gene in Iranian Azeri Turkish women with unexplained recurrent pregnancy loss.
Bagheri M; Abdi Rad I; Omrani MD; Nanbaksh F
Hum Fertil (Camb); 2010; 13(2):79-82. PubMed ID: 20722577
[TBL] [Abstract][Full Text] [Related]
37. Investigating Association of Three Polymorphisms of Coagulation Factor XIII and Recurrent Pregnancy Loss.
Jeddi-Tehrani M; Torabi R; Mohammadzadeh A; Arefi S; Keramatipour M; Zeraati H; Zarnani AH; Akhondi MM; Mahmoudian J; Mahmoudi AR; Zarei S
Am J Reprod Immunol; 2010 Sep; 64(3):212-7. PubMed ID: 20384622
[TBL] [Abstract][Full Text] [Related]
38. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
39. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
[TBL] [Abstract][Full Text] [Related]
40. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
